Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
87
Total Claims
$459K
Drug Cost
12
Beneficiaries
$38K
Cost/Patient
Risk Score Breakdown 37/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+523%
Opioid rate vs peers
39.1% vs 6.3% avg
+181%
Cost per patient vs peers
$38K vs $14K avg
+136%
Brand preference vs peers
34.5% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 523% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
39.1%
Opioid Rate
34
Opioid Claims
$4,197
Opioid Cost
44.1%
Long-Acting Rate
This provider's opioid prescribing rate of 39.1% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 30 claims · $458K
Generic: 57 claims · $1,120
Patient Profile
70
Avg Age
—
Female
1.54
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About